OpenURL Connection Search

Select item for more details and to access through your institution.

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.
Published in:
1994
By:
- Somlo, George;
- Doroshow, James H.;
- Forman, Stephen J.;
- Leong, Lucille A.;
- Margolin, Kim A.;
- Morgan, Robert J.;
- Raschko, James W.;
- Akman, Steven A.;
- Ahn, Chul;
- Nagasawa, Stuart;
- Harrison, Jonathan;
- Somlo, G;
- Doroshow, J H;
- Forman, S J;
- Leong, L A;
- Margolin, K A;
- Morgan, R J Jr;
- Raschko, J W;
- Akman, S A;
- Ahn, C
Publication type:
journal article
High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
Published in:
1994
By:
- Somlo, George;
- Doroshow, James H.;
- Forman, Stephen J.;
- Leong, Lucille A.;
- Margolin, Kim A.;
- Morgan, Robert J.;
- Raschko, James W.;
- Akman, Steven A.;
- Ahn, Chul;
- Sniecinski, Irena;
- Somlo, G;
- Doroshow, J H;
- Forman, S J;
- Leong, L A;
- Margolin, K A;
- Morgan, R J Jr;
- Raschko, J W;
- Akman, S A;
- Ahn, C;
- Sniecinski, I
Publication type:
journal article
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.
Published in:
2000
By:
- Tetef, Merry L.;
- Margolin, Kim A.;
- Doroshow, James H.;
- Akman, Steven;
- Leong, Lucille A.;
- Morgan Jr., Robert J.;
- Raschko, James W.;
- Slatkin, Neil;
- Somlo, George;
- Longmate, Jeffrey A.;
- Carroll, Mary I.;
- Newman, Edward M.;
- Tetef, M L;
- Margolin, K A;
- Doroshow, J H;
- Akman, S;
- Leong, L A;
- Morgan, R J Jr;
- Raschko, J W;
- Slatkin, N
Publication type:
journal article
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
Published in:
2001
By:
- Somlo, G.;
- Doroshow, J. H.;
- Synold, T.;
- Longmate, J.;
- Reardon, D.;
- Chow, W.;
- Forman, S. J.;
- Leong, L. A.;
- Margolin, K. A.;
- Morgan, Jr., R. J.;
- Raschko, J. W.;
- Shibata, S. I.;
- Tetef, M. L.;
- Yen, Y.;
- Kogut, N.;
- Schriber, J.;
- Alvarnas, J.;
- Morgan, R J Jr
Publication type:
journal article

Found: 4

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.

High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.

High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.